Axsome Q3 Auvelity Prescriptions ~302,000, Up 40% Y/Y; New Patient Starts Up 44%
Share
Why It Matters
Axsome sold way more of its medicine Auvelity this quarter. More people started using it, which shows doctors trust it more.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.